2011 Fiscal Year Final Research Report
Regulation of the dominant-negative-isoform of Ca^<2+>-activated K^+channel K_<Ca> 3.1 and its role in various diseases
| Project/Area Number |
21590098
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Biological pharmacy
|
|---|
| Research Institution | Nagoya City University |
|---|
Principal Investigator |
OHYA Susumu 名古屋市立大学, 大学院・薬学研究科, 准教授 (70275147)
|
|---|
| Project Period (FY) |
2009 – 2011
|
| Keywords | 薬理学 / イオンチャネル / Tリンパ球 / アレルギー性疾患 / 炎症性疾患 / 転写調節 |
|---|
| Research Abstract |
The novel spliced variant of intermediate-conductance Ca^<2+>-activated K^+channel K_<Ca> 3.1(K_<Ca> 3.1-sp/K_<Ca> 3.1b) has been identified from the human immune tissues, which were lacking the N-terminal domains of the original K_<Ca> 3.1a as a result of alternative splicing. The cellular distribution of CFP-tagged K_<Ca> 3.1a and/or YFP-tagged K_<Ca> 3.1-sp isoforms showed that K_<Ca> 3.1-sp suppressed the localization of K_<Ca> 3.1a to the plasma membrane, and co-expression of K_<Ca> 3.1-sp with K_<Ca> 3.1a suppressed IK_<Ca> channel activity of K_<Ca> 3.1a in a dominant-negative manner. In addition, the up-regulation and over-expression of K_<Ca> 3.1-sp suppressed thymocyte growth by down-regulation of IL-2 transcripts. These suggest that the N-terminal domain of K_<Ca> 3.1 is critical for channel trafficking to the plasma membrane, and that the fine tuning of IK_<Ca> channel activity modulated through alternative splicing may be related to the control in physiological and pathophysiological conditions in T-lymphocytes.
|
